These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 6364796

  • 1. Hyperglucagonemia in hepatic cirrhosis: its relation to hepatocellular dysfunction and normalization on recovery.
    Kabadi UM, Eisenstein AB, Tucci J, Pellicone J.
    Am J Gastroenterol; 1984 Feb; 79(2):143-9. PubMed ID: 6364796
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Serum T3 and reverse T3 levels in hepatic cirrhosis: relation to hepatocellular damage and normalization on improvement in liver dysfunction.
    Kabadi UM, Premachandra BN.
    Am J Gastroenterol; 1983 Nov; 78(11):750-5. PubMed ID: 6637968
    [Abstract] [Full Text] [Related]

  • 5. Hyperglucagonemia in cirrhosis: altered secretion and sensitivity to glucagon.
    Sherwin RS, Fisher M, Bessoff J, Snyder N, Hendler R, Conn HO, Felig P.
    Gastroenterology; 1978 Jun; 74(6):1224-8. PubMed ID: 648812
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Behavior of plasma insulin, C-peptide and glucagon in normal subjects and in patients with liver cirrhosis].
    Gragnoli G, Tanganelli I, Signorini AM.
    Boll Soc Ital Biol Sper; 1980 Jan 15; 56(1):69-75. PubMed ID: 7002168
    [Abstract] [Full Text] [Related]

  • 8. Serum lipids, insulin, and glucagon after portacaval shunt in cirrhosis.
    Shurberg JL, Resnick RH, Koff RS, Ros E, Baum RA, Pallotta JA.
    Gastroenterology; 1977 Feb 15; 72(2):301-4. PubMed ID: 830579
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics.
    Tietge UJ, Böker KH, Manns MP, Bahr MJ.
    Am J Physiol Endocrinol Metab; 2004 Jul 15; 287(1):E82-9. PubMed ID: 15010338
    [Abstract] [Full Text] [Related]

  • 11. [Blood glucose and glucoregulatory hormones in liver cirrhosis: a study of 24 hour profiles and of the role of portal-systemic shunting].
    Marchesini G, Zoli M, Dondi C, Angiolini A, Forlani G, Melli A, Bianchi FB, Pisi E.
    Gastroenterol Clin Biol; 1982 Mar 15; 6(3):272-8. PubMed ID: 7047286
    [No Abstract] [Full Text] [Related]

  • 12. Elevated plasma ammonia level in hepatic cirrhosis: role of glucagon.
    Kabadi UM, Eisenstein AB, Konda J.
    Gastroenterology; 1985 Mar 15; 88(3):750-6. PubMed ID: 3881308
    [Abstract] [Full Text] [Related]

  • 13. [Are disturbances of small intestinal motility associated with hyperglucagonemia in patients with liver cirrhosis?].
    Chesta J, Generini G, Antezana C, Defilippi C.
    Rev Med Chil; 1992 Sep 15; 120(9):998-1002. PubMed ID: 1340993
    [Abstract] [Full Text] [Related]

  • 14. Early and late changes in fasting and absorptive plasma amino acids and ammonia after distal splenorenal shunt in cirrhosis.
    Trevisani F, Bernardi M, Arienti V, Scrivano P, Mazziotti A, Cavallari A, Patrono D, Piazzi S, Gozzetti G, Gasbarrini G.
    Hepatology; 1994 Feb 15; 19(2):329-38. PubMed ID: 8294090
    [Abstract] [Full Text] [Related]

  • 15. Elevation of plasma glucagon-like immunoreactivity (GLI) in patients with liver cirrhosis.
    Watanabe A, Hashimoto M, Higashi T, Kobayashi M, Nakatsukasa H, Yamauchi Y, Watanabe M, Fujiwara M, Nagashima H.
    J Med; 1986 Feb 15; 17(2):95-108. PubMed ID: 3473162
    [Abstract] [Full Text] [Related]

  • 16. [Plasma lipids, insulin, C-peptide, and glucagon levels in cirrhosis: personal observations].
    Luca M, Sfogliano L, Privitera P, Noto R.
    Riv Eur Sci Med Farmacol; 1989 Apr 15; 11(2):113-22. PubMed ID: 2678305
    [Abstract] [Full Text] [Related]

  • 17. Glucose, insulin and somatostatin infusion for the determination of insulin resistance in liver cirrhosis.
    Greco AV, Rebuzzi AG, Altomonte L, Manna R, Bertoli A, Ghirlanda G.
    Horm Metab Res; 1979 Oct 15; 11(10):547-9. PubMed ID: 521009
    [Abstract] [Full Text] [Related]

  • 18. Mechanisms of hyperinsulinemia and hyperglucagonemia after liver transplantation.
    Sika M, Blair KT, Jabbour K, Williams PE, Donovan KL, Drougas JG, Becker YT, Bradley AL, Van Buren DH, Flakoll PJ, Chapman WC, Wright JK, Pinson CW.
    J Surg Res; 1997 Jul 01; 70(2):144-50. PubMed ID: 9245563
    [Abstract] [Full Text] [Related]

  • 19. Effects of transjugular intrahepatic portosystemic shunt (TIPS) on quantitative liver function tests.
    Baron A, Gulberg V, Sauter G, Waggershauser T, Reiser M, Gerbes AL.
    Hepatogastroenterology; 1998 Jul 01; 45(24):2315-21. PubMed ID: 9951915
    [Abstract] [Full Text] [Related]

  • 20. Effects of glucose on hepatic conversion of aminonitrogen to urea in patients with cirrhosis: relationship to glucagon.
    Hamberg O, Vilstrup H.
    Hepatology; 1994 Jan 01; 19(1):45-54. PubMed ID: 7903954
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.